"sharp drop"

#6274278

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269082

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269084

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269086

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269088

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269090

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269092

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269094

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269096

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269098

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269100

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269102

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6269104

12 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Pfizer pharmaceutical corporation logo. UK approved and rolled out the Pfizer/BioNTech vaccine while FDA approves the COVID-19 vaccine for emergency use in the US, reportedly by American media. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 12, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#3721806

28 January 2019

The Sao Paulo Stock Exchange lost nearly 3,000 points on 28 January 2019, with the sharp drop in the shares of Vale and Bradespar. The two companies' common shares lost about 19% early in the trading session, reflecting the tragedy in Brumadinho (MG) on the first trading day after that. The opening bid for the two stocks lasted more than normal, but the decline of the Ibovespa was moderate, following the negative variation of the European stock exchanges. At 1:18 pm, the Ibovespa fell 2.63%, to 95,105 points. At the same time, the ON shares of Vale were down 22.48%

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#3721812

28 January 2019

The Sao Paulo Stock Exchange lost nearly 3,000 points on 28 January 2019, with the sharp drop in the shares of Vale and Bradespar. The two companies' common shares lost about 19% early in the trading session, reflecting the tragedy in Brumadinho (MG) on the first trading day after that. The opening bid for the two stocks lasted more than normal, but the decline of the Ibovespa was moderate, following the negative variation of the European stock exchanges. At 1:18 pm, the Ibovespa fell 2.63%, to 95,105 points. At the same time, the ON shares of Vale were down 22.48%

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#3721830

28 January 2019

The Sao Paulo Stock Exchange lost nearly 3,000 points on 28 January 2019, with the sharp drop in the shares of Vale and Bradespar. The two companies' common shares lost about 19% early in the trading session, reflecting the tragedy in Brumadinho (MG) on the first trading day after that. The opening bid for the two stocks lasted more than normal, but the decline of the Ibovespa was moderate, following the negative variation of the European stock exchanges. At 1:18 pm, the Ibovespa fell 2.63%, to 95,105 points. At the same time, the ON shares of Vale were down 22.48%

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.